Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University

ISSN: 1875-5402 (Online)
ISSN: 1386-2073 (Print)

Volume 18, 10 Issues, 2015

Download PDF Flyer

Combinatorial Chemistry & High Throughput Screening

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 23rd of 71 in Chemistry, Applied

Submit Abstracts Online Submit Manuscripts Online

Rathnam Chaguturu
iDDPartners, 3 Edith Court
Princeton Junction
NJ 08550

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.925
5 - Year: 1.782

Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University

Author(s): Leonardo J. Solmesky and Miguel Weil

Affiliation: Cell Screening Facility for Personalized Medicine, Laboratory for Neurodegenerative Diseases and Personalized Medicine, Department of Cell Research and Immunology, The Sagol School of Neurosciences, The George S. Wise Faculty for Life Sciences, Tel Aviv University, Ramat Aviv 69978, Tel Aviv, Israel.


The Cell screening facility for personalized medicine (CSFPM) at Tel Aviv University in Israel is devoted to screening small molecules libraries for finding new drugs for rare diseases using human cell based models. The main strategy of the facility is based on smartly reducing the size of the compounds collection in similarity clusters and at the same time keeping high diversity of pharmacophores. This strategy allows parallel screening of several patient derived - cells in a personalized screening approach. The tested compounds are repositioned drugs derived from collections of phase III and FDA approved small molecules. In addition, the facility carries screenings using other chemical libraries and toxicological characterizations of nanomaterials.

Keywords: Drug repurposing, high content screening, nanomaterials characterization, personalized drug discovery, personalized medicine, rare diseases.

Download Free Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 17
Issue Number: 3
First Page: 253
Last Page: 255
Page Count: 3
DOI: 10.2174/1386207317666140109123249

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science